Biotech Reading List (April 2017)

Immuno-oncology (IO) combination therapy- why the angst? Part 1 - Part 2
Paul Rennert (Sugar Cone Biotech)

Alzheimer’s: Learning From a Legacy of Bitter Setbacks
Endpoints News

What it takes to create the future
David Baltimore (Timmerman Report)

With Neuralink, Elon Musk Promises Human-to-Human Telepathy. Don’t Believe It
Antonio Regalado (MIT Technology Review)

The Cost of Not Taking Your Medicine
Jane Brody (New York Times)